Short and Long-term Psychological Impact of Covid-19 on The Egyptians

Mental Health Issue Clinical Trial

Official title:

Psychological Impact of Covid-19 on The Egyptians

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04344834
• Other study ID #: Covid-19 mental health
• Status: Recruiting
• Start date: June 15, 2020
• Est. completion date: June 30, 2021

Study information

• Verified date: March 2021
• Source: Assiut University
• Contact: Gellan Ahmed, Phd
• Phone: +201093663928
• Email: gillankaram[@]aun.edu.eg
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The World Health Organization (WHO) has recently declared coronavirus disease 2019 (Covid-19) a public health emergency of international concern. Impact of the pandemic of covid-19 on the mental health of patients, health care workers and general population would be affected.

Description:

Health care workers and general population will be included in the study. A questionnaire will be used to assess their knowledge and practices regarding covid-19 and its impact on mental health.

Patients Mental health will be assessed regarding anxiety, depression and obsessive compulsive disorder, sleep disorder will be assessed.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 300
• Est. completion date: June 30, 2021
• Est. primary completion date: March 30, 2021
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Egyptian population

Exclusion Criteria:

• Patients not accepting to participate in the questionnaire

Related Conditions & MeSH terms

• Mental Health Issue

Intervention

Diagnostic Test:
• A questionnaire or scales
A questionnaire or scale to assess the participants mental health.

Locations

Country	Name	City	State
Egypt	Faculty of Medicine	Assiut

Sponsors (1)

Lead Sponsor	Collaborator
Assiut University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Depression	Hamilton depression scale:The total score is obtained by summing the score of each item, 0-4 (symptom is absent, mild, moderate, or severe). For the 17-item version, scores can range from 0 to 54.Where total scores between 0 and 7 do not indicate the presence of depression, scores between 8 and 13 indicate mild depression, scores between 14 and 18 indicate moderate depression, scores between 19 and 22 indicate severe depression and 23 score or more indicate very severe depression.	6 months
Primary	Anxiety	Hamilton anxiety scale:The scale consists of 14 items, each defined by a series of symptoms, and measures both psychic anxiety (mental agitation and psychological distress) and somatic anxiety (physical complaints related to anxiety).Each item is scored on a scale of 0 (not present) to 4 (severe), with a total score range of 0-56, where total score 0 -13=normal, 14-17 = mild anxiety, 18-24 = moderate anxiety, 25-30 = severe anxiety.	6 months
Primary	Obsessive compulsive disorder	Yale-Brown Obsessive Compulsive Scale (OCD): Each item is rated from 0 (no symptoms) to 4 (extreme symptoms). A score of 0-7 is considered nonclinical. Scores ranging between 8 and 15 are considered mild. Scores between 16 and 23 are considered moderate and scores between 24-31 and 32-40 are considered severe and extreme, respectively.	6 months
Primary	Sleep disorder	Pitsburgh sleep quality index	6 months
Primary	Psychological problems	Symptom checklist 90	6 months